Esposito Katherine, Ciotola Miryam, Giugliano Francesco, Sardelli Luigi, Giugliano Francesco, Maiorino Maria Ida, Beneduce Flora, De Sio Marco, Giugliano Dario
Department of Geriatrics and Metabolic Diseases, Division of Metabolic Diseases, Second University of Naples, Naples, Italy.
J Sex Med. 2008 Jun;5(6):1436-42. doi: 10.1111/j.1743-6109.2008.00823.x. Epub 2008 Apr 10.
Endothelial microparticles (EMPs) may play a role as biomarkers of vascular injury. EMPs are higher in men with diabetes diabetic men with erectile dysfunction (ED) than in nondiabetic potent men.
The aim of this study was to quantize different phenotypic circulating EMP levels among diabetic and nondiabetic patients with ED, and to determine whether EMPs are released as a result of activation or apoptosis.
We studied 30 type 2 diabetic and 24 nondiabetic subjects with symptomatic ED from at least 6 months, and 20 nondiabetic men without ED matched for age and weight with diabetic and nondiabetic subjects. Erectile function was assessed by completing the International Index of Erectile Function (IEEF)-5, which consists of Items 5, 15, 4, 2, and 7 from the full-scale IIEF-15. A score of 21 or less indicates the presence of ED.
EMP levels in plasma were quantified by flow cytometry. Markers for apoptosis (platelet/endothelial cell adhesion molecule 1/CD31 antigen) and activation (E-selectin/CD62E antigen) were compared. Endothelium-dependent flow-mediated dilation (FMD) was evaluated in the right brachial artery with a high-resolution ultrasound machine following reactive hyperemia.
Diabetic patients were found to have the highest levels of EMP31+; diabetic and nondiabetic men with ED were found to have significantly higher levels of EMP62+ than nondiabetic men without ED. The EMP62/EMP31 ratio, an index of endothelial activation (high ratio) or apoptosis (low ratio), was lowest in diabetic men with ED (0.20). In the whole group of 54 men with ED (diabetic and nondiabetic), there was an inverse correlation between FMD and the number of circulating EMPs (P < 0.05).
The presence of diabetes in subjects with ED is associated with a different pattern of endothelial cell injury. The phenotypic assessment of EMPs in diabetic patients with ED is consistent with increased apoptotic activity.
内皮微粒(EMPs)可能作为血管损伤的生物标志物。患有糖尿病且伴有勃起功能障碍(ED)的男性体内的EMPs水平高于非糖尿病且性功能正常的男性。
本研究旨在量化患有ED的糖尿病患者和非糖尿病患者中不同表型循环EMPs的水平,并确定EMPs是否因激活或凋亡而释放。
我们研究了30名患有症状性ED至少6个月的2型糖尿病患者和24名非糖尿病患者,以及20名年龄和体重与糖尿病和非糖尿病患者相匹配的无ED的非糖尿病男性。通过完成国际勃起功能指数(IEEF)-5来评估勃起功能,该指数由完整的IIEF-15中的第5、15、4、2和7项组成。得分21分及以下表明存在ED。
通过流式细胞术量化血浆中的EMPs水平。比较凋亡标志物(血小板/内皮细胞黏附分子1/CD31抗原)和激活标志物(E-选择素/CD62E抗原)。在反应性充血后,使用高分辨率超声仪在右肱动脉中评估内皮依赖性血流介导的血管舒张(FMD)。
发现糖尿病患者的EMP31+水平最高;患有ED的糖尿病和非糖尿病男性的EMP62+水平显著高于无ED的非糖尿病男性。EMP62/EMP31比值是内皮激活(高比值)或凋亡(低比值)的指标,在患有ED的糖尿病男性中最低(0.20)。在整个54名患有ED的男性(糖尿病和非糖尿病)组中,FMD与循环EMPs数量之间存在负相关(P<0.05)。
患有ED的受试者中糖尿病的存在与内皮细胞损伤的不同模式相关。患有ED的糖尿病患者中EMPs的表型评估与凋亡活性增加一致。